BioCentury | Nov 9, 2009
Financial News

Metabolex completes venture financing

...City Capital; VantagePoint Venture Partners; Novo Ventures; Pictet Funds; Next Chapter Holdings; Charter Venture Capital; Merlin BioMed Group...
BioCentury | May 25, 2009
Finance

Ebb & Flow

...million private placement led by Adage Capital. Other investors included Brookside Capital; T. Rowe Price; Merlin BioMed Group...
BioCentury | Jul 1, 2008
Financial News

Gemin X raises $38 million

...Sciences Fund and Caxton Global. Existing investors Sanderling Ventures; H.I.G. Ventures; CDP/Vantage Point; ProQuest ; Merlin BioMed Group...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...series B, 2001 Aberdare Ventures; Abingworth Management; Bay City Capital; Domain Associates; HealthCap; Invemed Associates; Merlin BioMed Group...
...addressing various GI disorders 2004 $55M series D, 2004 ATEL Ventures; Itochu; JAFCO; MPM Capital; Merlin BioMed Group...
...Advisors; Scottish Widows Investment Partnership $30M series E, 2006 Ascent Biomedical Ventures; JAFCO; MPM Capital; Merlin BioMed Group...
BioCentury | Jan 14, 2008
Finance

2008 Financial Markets Preview: Looking for an oasis

...said. Among biotech-focused hedge funds, he observed a thinning of the ranks. Cooper Hill Partners, Merlin BioMed...
BioCentury | Oct 29, 2007
Finance

Ebb & Flow

...led that 2002 deal for $17.8 million, with other investors including OrbiMed Advisors; DWS Investments; Merlin BioMed...
BioCentury | Oct 1, 2007
Finance

4Q Financial Markets Preview: Wing and a prayer

...interest rate is that "it makes long dated assets worth more," noted Stuart Weisbrod of Merlin Biomed...
BioCentury | Sep 10, 2007
Finance

Ebb & Flow

...events when administered to target a hemoglobin of greater than 12 g/L. Stuart Weisbrod of Merlin BioMed...
BioCentury | Sep 10, 2007
Finance

Bringing up BIIB

...Biogen Idec," Marti told Ebb & Flow. A contrarian view came from Stuart Wisebrod of Merlin BioMed...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...couple of big biotech/pharma companies as investors. New investors Biogen Idec (BIIB); Bessemer Venture Partners; Merlin BioMed Group...
Items per page:
1 - 10 of 59
BioCentury | Nov 9, 2009
Financial News

Metabolex completes venture financing

...City Capital; VantagePoint Venture Partners; Novo Ventures; Pictet Funds; Next Chapter Holdings; Charter Venture Capital; Merlin BioMed Group...
BioCentury | May 25, 2009
Finance

Ebb & Flow

...million private placement led by Adage Capital. Other investors included Brookside Capital; T. Rowe Price; Merlin BioMed Group...
BioCentury | Jul 1, 2008
Financial News

Gemin X raises $38 million

...Sciences Fund and Caxton Global. Existing investors Sanderling Ventures; H.I.G. Ventures; CDP/Vantage Point; ProQuest ; Merlin BioMed Group...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...series B, 2001 Aberdare Ventures; Abingworth Management; Bay City Capital; Domain Associates; HealthCap; Invemed Associates; Merlin BioMed Group...
...addressing various GI disorders 2004 $55M series D, 2004 ATEL Ventures; Itochu; JAFCO; MPM Capital; Merlin BioMed Group...
...Advisors; Scottish Widows Investment Partnership $30M series E, 2006 Ascent Biomedical Ventures; JAFCO; MPM Capital; Merlin BioMed Group...
BioCentury | Jan 14, 2008
Finance

2008 Financial Markets Preview: Looking for an oasis

...said. Among biotech-focused hedge funds, he observed a thinning of the ranks. Cooper Hill Partners, Merlin BioMed...
BioCentury | Oct 29, 2007
Finance

Ebb & Flow

...led that 2002 deal for $17.8 million, with other investors including OrbiMed Advisors; DWS Investments; Merlin BioMed...
BioCentury | Oct 1, 2007
Finance

4Q Financial Markets Preview: Wing and a prayer

...interest rate is that "it makes long dated assets worth more," noted Stuart Weisbrod of Merlin Biomed...
BioCentury | Sep 10, 2007
Finance

Ebb & Flow

...events when administered to target a hemoglobin of greater than 12 g/L. Stuart Weisbrod of Merlin BioMed...
BioCentury | Sep 10, 2007
Finance

Bringing up BIIB

...Biogen Idec," Marti told Ebb & Flow. A contrarian view came from Stuart Wisebrod of Merlin BioMed...
BioCentury | May 7, 2007
Finance

Ebb & Flow

...couple of big biotech/pharma companies as investors. New investors Biogen Idec (BIIB); Bessemer Venture Partners; Merlin BioMed Group...
Items per page:
1 - 10 of 59